Copyright Reports & Markets. All rights reserved.

Global Small Animal Imaging (In-vivo) Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Small Animal Imaging (In-vivo) Industry
  • 1.7 COVID-19 Impact: Small Animal Imaging (In-vivo) Market Trends

    • 2 Global Small Animal Imaging (In-vivo) Quarterly Market Size Analysis

    • 2.1 Small Animal Imaging (In-vivo) Business Impact Assessment - COVID-19
      • 2.1.1 Global Small Animal Imaging (In-vivo) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Small Animal Imaging (In-vivo) Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Small Animal Imaging (In-vivo) Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Small Animal Imaging (In-vivo) Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Small Animal Imaging (In-vivo) Market
    • 3.4 Key Players Small Animal Imaging (In-vivo) Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Small Animal Imaging (In-vivo) Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Micro-MRI
      • 1.4.2 Optical
      • 1.4.3 Nuclear
    • 4.2 By Type, Global Small Animal Imaging (In-vivo) Market Size, 2019-2021

    5 Impact of Covid-19 on Small Animal Imaging (In-vivo) Segments, By Application

    • 5.1 Overview
      • 5.5.1 Monitoring Treatment Response
      • 5.5.2 Bio-distribution
      • 5.5.3 Determining Drug/Target Engagement
      • 5.5.4 Cancer Cell Detection
      • 5.5.5 Biomarkers
      • 5.5.6 Longitudinal Studies
      • 5.5.7 Epigenetics
    • 5.2 By Application, Global Small Animal Imaging (In-vivo) Market Size, 2019-2021
      • 5.2.1 By Application, Global Small Animal Imaging (In-vivo) Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Thermo Fisher Scientific
      • 7.1.1 Thermo Fisher Scientific Business Overview
      • 7.1.2 Thermo Fisher Scientific Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.1.3 Thermo Fisher Scientific Small Animal Imaging (In-vivo) Product Introduction
      • 7.1.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
    • 7.2 Siemens AG
      • 7.2.1 Siemens AG Business Overview
      • 7.2.2 Siemens AG Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.2.3 Siemens AG Small Animal Imaging (In-vivo) Product Introduction
      • 7.2.4 Siemens AG Response to COVID-19 and Related Developments
    • 7.3 Life Technologies Corporation
      • 7.3.1 Life Technologies Corporation Business Overview
      • 7.3.2 Life Technologies Corporation Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.3.3 Life Technologies Corporation Small Animal Imaging (In-vivo) Product Introduction
      • 7.3.4 Life Technologies Corporation Response to COVID-19 and Related Developments
    • 7.4 Bruker Corporation
      • 7.4.1 Bruker Corporation Business Overview
      • 7.4.2 Bruker Corporation Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.4.3 Bruker Corporation Small Animal Imaging (In-vivo) Product Introduction
      • 7.4.4 Bruker Corporation Response to COVID-19 and Related Developments
    • 7.5 PerkinElmer, Inc
      • 7.5.1 PerkinElmer, Inc Business Overview
      • 7.5.2 PerkinElmer, Inc Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.5.3 PerkinElmer, Inc Small Animal Imaging (In-vivo) Product Introduction
      • 7.5.4 PerkinElmer, Inc Response to COVID-19 and Related Developments
    • 7.6 Aspect Imaging Ltd.
      • 7.6.1 Aspect Imaging Ltd. Business Overview
      • 7.6.2 Aspect Imaging Ltd. Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.6.3 Aspect Imaging Ltd. Small Animal Imaging (In-vivo) Product Introduction
      • 7.6.4 Aspect Imaging Ltd. Response to COVID-19 and Related Developments
    • 7.7 Promega Corporation
      • 7.7.1 Promega Corporation Business Overview
      • 7.7.2 Promega Corporation Small Animal Imaging (In-vivo) Quarterly Revenue, 2020
      • 7.7.3 Promega Corporation Small Animal Imaging (In-vivo) Product Introduction
      • 7.7.4 Promega Corporation Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Small Animal Imaging (In-vivo), including the following market information:
      Global Small Animal Imaging (In-vivo) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Small Animal Imaging (In-vivo) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Small Animal Imaging (In-vivo) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Small Animal Imaging (In-vivo) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Thermo Fisher Scientific, Siemens AG, Life Technologies Corporation, Bruker Corporation, PerkinElmer, Inc, Aspect Imaging Ltd., Promega Corporation, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Micro-MRI
      Optical
      Nuclear

      Based on the Application:
      Monitoring Treatment Response
      Bio-distribution
      Determining Drug/Target Engagement
      Cancer Cell Detection
      Biomarkers
      Longitudinal Studies
      Epigenetics

      Buy now